chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebral ventricle dilatation, Chest X-ray abnormal, Computerised tomogram abdomen abnormal, Computerised tomogram thorax abnormal, Confusional state
Clinical narrative: Patient expired.  66 y.o. male with past medical history significant for type 2 diabetes, vascular dementia, AFib on Eliquis, CHF, depression, chronic anemia, recent DVT/PE, chronic hypoxic respiratory failure who presented to emergency department with altered mental status. Upon arrival to emergency department, patient was febrile but other vitals were stable.  Baseline blood work was obtained which was remarkable for leukocytosis of 16. Lactic acid was normal.  Suprapubic catheter was changed in UA was obtained.  UA positive for acute infection.  Viral PCR negative.  CXR was obtained showing worsening bilateral infiltrates consistent with pneumonia.  CT abdomen and pelvis was obtained showing mild sigmoid colon diverticulosis without diverticulitis.  Mild to moderate large volume of stool.  Ultrasound of lower extremities was obtained which was negative acute DVT.  Blood cultures were obtained and patient was started on cefepime, vancomycin and azithromycin.  He was also given a 2 L NS bolus.  Patient was then transferred to Hospital and admitted to General Medicine for further evaluation and management.   Patient was initially confused and this had resolved after the 1st 48 hours of stay.  Neurology consulted per family's request and they agreed that this confusion is secondary to acute toxic metabolic encephalopathy related to his COVID and hypoxia.   Patient continued on oxygen support.  Patient had been requiring high-flow nasal cannula support.  Infectious Disease consulted with MRSA screen positive.  Workups showed positive COVID and the rest were negative.  Antibiotics then discontinued.  IV steroids then initiated.  Pulmonary consulted and evaluated patient. Agreed on IV steroids.  Chest CT performed and showed extensive bilateral ground-glass opacities with probable developing fibrosis as a sequelae of his previous COVID-19 pneumonia.  Patient was saturating well with his high-flow nasal cannula oxygen support.  Patient noted to have aspiration episodes that SLP consulted, performed FEES which did show significant aspirations and recommended NPO.  Patient noted to have no capacity to make decision about risks of eating and benefits of feeding tube placement and decisions on advance care planning.  Neuropsych had been consulted for this and evaluated patient.  Patient deemed to have no medical decision making capacity on this. DPOA then activated.  Initiated goals of care discussion with medical DPOA who was receptive of palliative care involvement and hospice informational meeting.  Upon seeing patient on 02/14/2022, DPOA decided on to proceed with comfort care measures.  Comfort care measures then had been initiated.  Hospice service followed and patient deemed to meet criteria for hospice on 2/15/2021.  The patient passed away and was pronounced on 2/17/2022 at 1200pm.  Cause of death is COVID-19 pneumonia and secondary bacterial pneumonia + Sepsis.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Deep vein thrombosis, Dental caries, Diverticulum intestinal, Dyspnoea
Clinical narrative: Patient expired.  66 y.o. male with past medical history significant for type 2 diabetes, vascular dementia, AFib on Eliquis, CHF, depression, chronic anemia, recent DVT/PE, chronic hypoxic respiratory failure who presented to emergency department with altered mental status. Upon arrival to emergency department, patient was febrile but other vitals were stable.  Baseline blood work was obtained which was remarkable for leukocytosis of 16. Lactic acid was normal.  Suprapubic catheter was changed in UA was obtained.  UA positive for acute infection.  Viral PCR negative.  CXR was obtained showing worsening bilateral infiltrates consistent with pneumonia.  CT abdomen and pelvis was obtained showing mild sigmoid colon diverticulosis without diverticulitis.  Mild to moderate large volume of stool.  Ultrasound of lower extremities was obtained which was negative acute DVT.  Blood cultures were obtained and patient was started on cefepime, vancomycin and azithromycin.  He was also given a 2 L NS bolus.  Patient was then transferred to Hospital and admitted to General Medicine for further evaluation and management.   Patient was initially confused and this had resolved after the 1st 48 hours of stay.  Neurology consulted per family's request and they agreed that this confusion is secondary to acute toxic metabolic encephalopathy related to his COVID and hypoxia.   Patient continued on oxygen support.  Patient had been requiring high-flow nasal cannula support.  Infectious Disease consulted with MRSA screen positive.  Workups showed positive COVID and the rest were negative.  Antibiotics then discontinued.  IV steroids then initiated.  Pulmonary consulted and evaluated patient. Agreed on IV steroids.  Chest CT performed and showed extensive bilateral ground-glass opacities with probable developing fibrosis as a sequelae of his previous COVID-19 pneumonia.  Patient was saturating well with his high-flow nasal cannula oxygen support.  Patient noted to have aspiration episodes that SLP consulted, performed FEES which did show significant aspirations and recommended NPO.  Patient noted to have no capacity to make decision about risks of eating and benefits of feeding tube placement and decisions on advance care planning.  Neuropsych had been consulted for this and evaluated patient.  Patient deemed to have no medical decision making capacity on this. DPOA then activated.  Initiated goals of care discussion with medical DPOA who was receptive of palliative care involvement and hospice informational meeting.  Upon seeing patient on 02/14/2022, DPOA decided on to proceed with comfort care measures.  Comfort care measures then had been initiated.  Hospice service followed and patient deemed to meet criteria for hospice on 2/15/2021.  The patient passed away and was pronounced on 2/17/2022 at 1200pm.  Cause of death is COVID-19 pneumonia and secondary bacterial pneumonia + Sepsis.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Endoscopic swallowing evaluation abnormal, Fibrosis, Hypoxia, Infection, Leukocytosis
Clinical narrative: Patient expired.  66 y.o. male with past medical history significant for type 2 diabetes, vascular dementia, AFib on Eliquis, CHF, depression, chronic anemia, recent DVT/PE, chronic hypoxic respiratory failure who presented to emergency department with altered mental status. Upon arrival to emergency department, patient was febrile but other vitals were stable.  Baseline blood work was obtained which was remarkable for leukocytosis of 16. Lactic acid was normal.  Suprapubic catheter was changed in UA was obtained.  UA positive for acute infection.  Viral PCR negative.  CXR was obtained showing worsening bilateral infiltrates consistent with pneumonia.  CT abdomen and pelvis was obtained showing mild sigmoid colon diverticulosis without diverticulitis.  Mild to moderate large volume of stool.  Ultrasound of lower extremities was obtained which was negative acute DVT.  Blood cultures were obtained and patient was started on cefepime, vancomycin and azithromycin.  He was also given a 2 L NS bolus.  Patient was then transferred to Hospital and admitted to General Medicine for further evaluation and management.   Patient was initially confused and this had resolved after the 1st 48 hours of stay.  Neurology consulted per family's request and they agreed that this confusion is secondary to acute toxic metabolic encephalopathy related to his COVID and hypoxia.   Patient continued on oxygen support.  Patient had been requiring high-flow nasal cannula support.  Infectious Disease consulted with MRSA screen positive.  Workups showed positive COVID and the rest were negative.  Antibiotics then discontinued.  IV steroids then initiated.  Pulmonary consulted and evaluated patient. Agreed on IV steroids.  Chest CT performed and showed extensive bilateral ground-glass opacities with probable developing fibrosis as a sequelae of his previous COVID-19 pneumonia.  Patient was saturating well with his high-flow nasal cannula oxygen support.  Patient noted to have aspiration episodes that SLP consulted, performed FEES which did show significant aspirations and recommended NPO.  Patient noted to have no capacity to make decision about risks of eating and benefits of feeding tube placement and decisions on advance care planning.  Neuropsych had been consulted for this and evaluated patient.  Patient deemed to have no medical decision making capacity on this. DPOA then activated.  Initiated goals of care discussion with medical DPOA who was receptive of palliative care involvement and hospice informational meeting.  Upon seeing patient on 02/14/2022, DPOA decided on to proceed with comfort care measures.  Comfort care measures then had been initiated.  Hospice service followed and patient deemed to meet criteria for hospice on 2/15/2021.  The patient passed away and was pronounced on 2/17/2022 at 1200pm.  Cause of death is COVID-19 pneumonia and secondary bacterial pneumonia + Sepsis.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Lung disorder, Lung infiltration, Lung opacity, Mental status changes, Pneumonia bacterial
Clinical narrative: Patient expired.  66 y.o. male with past medical history significant for type 2 diabetes, vascular dementia, AFib on Eliquis, CHF, depression, chronic anemia, recent DVT/PE, chronic hypoxic respiratory failure who presented to emergency department with altered mental status. Upon arrival to emergency department, patient was febrile but other vitals were stable.  Baseline blood work was obtained which was remarkable for leukocytosis of 16. Lactic acid was normal.  Suprapubic catheter was changed in UA was obtained.  UA positive for acute infection.  Viral PCR negative.  CXR was obtained showing worsening bilateral infiltrates consistent with pneumonia.  CT abdomen and pelvis was obtained showing mild sigmoid colon diverticulosis without diverticulitis.  Mild to moderate large volume of stool.  Ultrasound of lower extremities was obtained which was negative acute DVT.  Blood cultures were obtained and patient was started on cefepime, vancomycin and azithromycin.  He was also given a 2 L NS bolus.  Patient was then transferred to Hospital and admitted to General Medicine for further evaluation and management.   Patient was initially confused and this had resolved after the 1st 48 hours of stay.  Neurology consulted per family's request and they agreed that this confusion is secondary to acute toxic metabolic encephalopathy related to his COVID and hypoxia.   Patient continued on oxygen support.  Patient had been requiring high-flow nasal cannula support.  Infectious Disease consulted with MRSA screen positive.  Workups showed positive COVID and the rest were negative.  Antibiotics then discontinued.  IV steroids then initiated.  Pulmonary consulted and evaluated patient. Agreed on IV steroids.  Chest CT performed and showed extensive bilateral ground-glass opacities with probable developing fibrosis as a sequelae of his previous COVID-19 pneumonia.  Patient was saturating well with his high-flow nasal cannula oxygen support.  Patient noted to have aspiration episodes that SLP consulted, performed FEES which did show significant aspirations and recommended NPO.  Patient noted to have no capacity to make decision about risks of eating and benefits of feeding tube placement and decisions on advance care planning.  Neuropsych had been consulted for this and evaluated patient.  Patient deemed to have no medical decision making capacity on this. DPOA then activated.  Initiated goals of care discussion with medical DPOA who was receptive of palliative care involvement and hospice informational meeting.  Upon seeing patient on 02/14/2022, DPOA decided on to proceed with comfort care measures.  Comfort care measures then had been initiated.  Hospice service followed and patient deemed to meet criteria for hospice on 2/15/2021.  The patient passed away and was pronounced on 2/17/2022 at 1200pm.  Cause of death is COVID-19 pneumonia and secondary bacterial pneumonia + Sepsis.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary embolism, Pyrexia, Respiratory failure, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Patient expired.  66 y.o. male with past medical history significant for type 2 diabetes, vascular dementia, AFib on Eliquis, CHF, depression, chronic anemia, recent DVT/PE, chronic hypoxic respiratory failure who presented to emergency department with altered mental status. Upon arrival to emergency department, patient was febrile but other vitals were stable.  Baseline blood work was obtained which was remarkable for leukocytosis of 16. Lactic acid was normal.  Suprapubic catheter was changed in UA was obtained.  UA positive for acute infection.  Viral PCR negative.  CXR was obtained showing worsening bilateral infiltrates consistent with pneumonia.  CT abdomen and pelvis was obtained showing mild sigmoid colon diverticulosis without diverticulitis.  Mild to moderate large volume of stool.  Ultrasound of lower extremities was obtained which was negative acute DVT.  Blood cultures were obtained and patient was started on cefepime, vancomycin and azithromycin.  He was also given a 2 L NS bolus.  Patient was then transferred to Hospital and admitted to General Medicine for further evaluation and management.   Patient was initially confused and this had resolved after the 1st 48 hours of stay.  Neurology consulted per family's request and they agreed that this confusion is secondary to acute toxic metabolic encephalopathy related to his COVID and hypoxia.   Patient continued on oxygen support.  Patient had been requiring high-flow nasal cannula support.  Infectious Disease consulted with MRSA screen positive.  Workups showed positive COVID and the rest were negative.  Antibiotics then discontinued.  IV steroids then initiated.  Pulmonary consulted and evaluated patient. Agreed on IV steroids.  Chest CT performed and showed extensive bilateral ground-glass opacities with probable developing fibrosis as a sequelae of his previous COVID-19 pneumonia.  Patient was saturating well with his high-flow nasal cannula oxygen support.  Patient noted to have aspiration episodes that SLP consulted, performed FEES which did show significant aspirations and recommended NPO.  Patient noted to have no capacity to make decision about risks of eating and benefits of feeding tube placement and decisions on advance care planning.  Neuropsych had been consulted for this and evaluated patient.  Patient deemed to have no medical decision making capacity on this. DPOA then activated.  Initiated goals of care discussion with medical DPOA who was receptive of palliative care involvement and hospice informational meeting.  Upon seeing patient on 02/14/2022, DPOA decided on to proceed with comfort care measures.  Comfort care measures then had been initiated.  Hospice service followed and patient deemed to meet criteria for hospice on 2/15/2021.  The patient passed away and was pronounced on 2/17/2022 at 1200pm.  Cause of death is COVID-19 pneumonia and secondary bacterial pneumonia + Sepsis.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Staphylococcus test positive, Tooth disorder, Toxic encephalopathy, Ultrasound Doppler normal, Urine analysis abnormal
Clinical narrative: Patient expired.  66 y.o. male with past medical history significant for type 2 diabetes, vascular dementia, AFib on Eliquis, CHF, depression, chronic anemia, recent DVT/PE, chronic hypoxic respiratory failure who presented to emergency department with altered mental status. Upon arrival to emergency department, patient was febrile but other vitals were stable.  Baseline blood work was obtained which was remarkable for leukocytosis of 16. Lactic acid was normal.  Suprapubic catheter was changed in UA was obtained.  UA positive for acute infection.  Viral PCR negative.  CXR was obtained showing worsening bilateral infiltrates consistent with pneumonia.  CT abdomen and pelvis was obtained showing mild sigmoid colon diverticulosis without diverticulitis.  Mild to moderate large volume of stool.  Ultrasound of lower extremities was obtained which was negative acute DVT.  Blood cultures were obtained and patient was started on cefepime, vancomycin and azithromycin.  He was also given a 2 L NS bolus.  Patient was then transferred to Hospital and admitted to General Medicine for further evaluation and management.   Patient was initially confused and this had resolved after the 1st 48 hours of stay.  Neurology consulted per family's request and they agreed that this confusion is secondary to acute toxic metabolic encephalopathy related to his COVID and hypoxia.   Patient continued on oxygen support.  Patient had been requiring high-flow nasal cannula support.  Infectious Disease consulted with MRSA screen positive.  Workups showed positive COVID and the rest were negative.  Antibiotics then discontinued.  IV steroids then initiated.  Pulmonary consulted and evaluated patient. Agreed on IV steroids.  Chest CT performed and showed extensive bilateral ground-glass opacities with probable developing fibrosis as a sequelae of his previous COVID-19 pneumonia.  Patient was saturating well with his high-flow nasal cannula oxygen support.  Patient noted to have aspiration episodes that SLP consulted, performed FEES which did show significant aspirations and recommended NPO.  Patient noted to have no capacity to make decision about risks of eating and benefits of feeding tube placement and decisions on advance care planning.  Neuropsych had been consulted for this and evaluated patient.  Patient deemed to have no medical decision making capacity on this. DPOA then activated.  Initiated goals of care discussion with medical DPOA who was receptive of palliative care involvement and hospice informational meeting.  Upon seeing patient on 02/14/2022, DPOA decided on to proceed with comfort care measures.  Comfort care measures then had been initiated.  Hospice service followed and patient deemed to meet criteria for hospice on 2/15/2021.  The patient passed away and was pronounced on 2/17/2022 at 1200pm.  Cause of death is COVID-19 pneumonia and secondary bacterial pneumonia + Sepsis.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Viral test negative, White blood cell count increased
Clinical narrative: Patient expired.  66 y.o. male with past medical history significant for type 2 diabetes, vascular dementia, AFib on Eliquis, CHF, depression, chronic anemia, recent DVT/PE, chronic hypoxic respiratory failure who presented to emergency department with altered mental status. Upon arrival to emergency department, patient was febrile but other vitals were stable.  Baseline blood work was obtained which was remarkable for leukocytosis of 16. Lactic acid was normal.  Suprapubic catheter was changed in UA was obtained.  UA positive for acute infection.  Viral PCR negative.  CXR was obtained showing worsening bilateral infiltrates consistent with pneumonia.  CT abdomen and pelvis was obtained showing mild sigmoid colon diverticulosis without diverticulitis.  Mild to moderate large volume of stool.  Ultrasound of lower extremities was obtained which was negative acute DVT.  Blood cultures were obtained and patient was started on cefepime, vancomycin and azithromycin.  He was also given a 2 L NS bolus.  Patient was then transferred to Hospital and admitted to General Medicine for further evaluation and management.   Patient was initially confused and this had resolved after the 1st 48 hours of stay.  Neurology consulted per family's request and they agreed that this confusion is secondary to acute toxic metabolic encephalopathy related to his COVID and hypoxia.   Patient continued on oxygen support.  Patient had been requiring high-flow nasal cannula support.  Infectious Disease consulted with MRSA screen positive.  Workups showed positive COVID and the rest were negative.  Antibiotics then discontinued.  IV steroids then initiated.  Pulmonary consulted and evaluated patient. Agreed on IV steroids.  Chest CT performed and showed extensive bilateral ground-glass opacities with probable developing fibrosis as a sequelae of his previous COVID-19 pneumonia.  Patient was saturating well with his high-flow nasal cannula oxygen support.  Patient noted to have aspiration episodes that SLP consulted, performed FEES which did show significant aspirations and recommended NPO.  Patient noted to have no capacity to make decision about risks of eating and benefits of feeding tube placement and decisions on advance care planning.  Neuropsych had been consulted for this and evaluated patient.  Patient deemed to have no medical decision making capacity on this. DPOA then activated.  Initiated goals of care discussion with medical DPOA who was receptive of palliative care involvement and hospice informational meeting.  Upon seeing patient on 02/14/2022, DPOA decided on to proceed with comfort care measures.  Comfort care measures then had been initiated.  Hospice service followed and patient deemed to meet criteria for hospice on 2/15/2021.  The patient passed away and was pronounced on 2/17/2022 at 1200pm.  Cause of death is COVID-19 pneumonia and secondary bacterial pneumonia + Sepsis.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure abnormal, Heart rate increased, Pulse abnormal
Clinical narrative: Unstable blood pressure and rapid pulse. Unstable pulse and unstable blood pressure continues, following 1st and 2nd Covid-19 2019 injection.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: PATIENT COMPLAINT ABOUT HAVING A THIRD BREAST UNDER THE ARM PIT. UPON RESEARCH IT WAS TOLD THAT IT COULD BE SWOLLEN LYMPH NODES DUE TO PFIZER VACCINE BUT SHE SHOULD GET IT CHECKED BY HER DOCOTR TO RULE OUT CANCER IF THE ISSUE IS NOT RESOLVED IN 7 DAYS. SHE WAS RECOMMENDED TO APPLY COLD COMPRESS.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Autoimmune arthritis, Blood test, Joint swelling
Clinical narrative: Developed autoimmune inflammatory arthritis. Pain and swelling experienced in knees, wrists, and hands.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Developed autoimmune inflammatory arthritis. Pain and swelling experienced in knees, wrists, and hands.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Acrochordon, Condition aggravated, Rash
Clinical narrative: I've had reactions to all three dosages, which includes a rash around my ears and neck, but this time, I've developed clusters of (what appears to be) skin tags near the rash site. All three episodes is/was more active on my left side, which is the side I received all three vaccines, due to being diagnosed with breast cancer 3/2021.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site pain, Pain, Pyrexia
Clinical narrative: EE had a fever, HA, Chills, body aches, soreness at injection site.  EE treated with Tylenol at home.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Pain in extremity
Clinical narrative: Patient received third dose early.  Outcome: Patient had a sore arm
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Autoimmune disorder, Back pain, Blood test, Chest X-ray, Chest pain
Clinical narrative: Within minutes of getting shot I had motion sickness, I had severe Vertigo. I could not drive home. Very dizzy and nauseated. I started getting neck pain and my range of motion was limited. I started getting shooting pain in my neck, It was happening 6-8 times a day. It was affecting my vision waking me up at night with jolting pain. That lasted about a month. I also was very short of breath and my legs felt fatigued and experienced muscle pains. I felt normal for a few months. I started to ease back into Yoga, I was unable to. I started to develop sternum pain and lower back pain. At my physical in December, I started Physical Therapy. I did see a rheumatologist, They believe maybe I have an autoimmune disease possibly triggered by vaccine, I do not know. I did notice a huge decline in my general health.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Impaired driving ability, Joint range of motion decreased, Limb discomfort
Clinical narrative: Within minutes of getting shot I had motion sickness, I had severe Vertigo. I could not drive home. Very dizzy and nauseated. I started getting neck pain and my range of motion was limited. I started getting shooting pain in my neck, It was happening 6-8 times a day. It was affecting my vision waking me up at night with jolting pain. That lasted about a month. I also was very short of breath and my legs felt fatigued and experienced muscle pains. I felt normal for a few months. I started to ease back into Yoga, I was unable to. I started to develop sternum pain and lower back pain. At my physical in December, I started Physical Therapy. I did see a rheumatologist, They believe maybe I have an autoimmune disease possibly triggered by vaccine, I do not know. I did notice a huge decline in my general health.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Motion sickness, Myalgia, Nausea, Neck pain, Pain
Clinical narrative: Within minutes of getting shot I had motion sickness, I had severe Vertigo. I could not drive home. Very dizzy and nauseated. I started getting neck pain and my range of motion was limited. I started getting shooting pain in my neck, It was happening 6-8 times a day. It was affecting my vision waking me up at night with jolting pain. That lasted about a month. I also was very short of breath and my legs felt fatigued and experienced muscle pains. I felt normal for a few months. I started to ease back into Yoga, I was unable to. I started to develop sternum pain and lower back pain. At my physical in December, I started Physical Therapy. I did see a rheumatologist, They believe maybe I have an autoimmune disease possibly triggered by vaccine, I do not know. I did notice a huge decline in my general health.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder, Vertigo, Visual impairment
Clinical narrative: Within minutes of getting shot I had motion sickness, I had severe Vertigo. I could not drive home. Very dizzy and nauseated. I started getting neck pain and my range of motion was limited. I started getting shooting pain in my neck, It was happening 6-8 times a day. It was affecting my vision waking me up at night with jolting pain. That lasted about a month. I also was very short of breath and my legs felt fatigued and experienced muscle pains. I felt normal for a few months. I started to ease back into Yoga, I was unable to. I started to develop sternum pain and lower back pain. At my physical in December, I started Physical Therapy. I did see a rheumatologist, They believe maybe I have an autoimmune disease possibly triggered by vaccine, I do not know. I did notice a huge decline in my general health.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Bursitis, Injection site hypoaesthesia, Injection site pain
Clinical narrative: On the day of injection, I had arm pain and numbness at the injection site. Within days, I started to develop pain in my left elbow. On January 3, the symptoms peaked, as I had a bursa (fluid sack) on my left elbow. The bursa went away in about a week. The pain, consistent with ulnar nerve entrapment, has fluctuated (come and gone), and I now have similar pain in my right elbow and sometimes in my right knee. I did not have these symptoms before the booster shot. I have used home care, exercise, and changed sleeping positions to accommodate the pain, but have shown minimal improvement.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient was given the "booster" (3rd dose) 12 days before the required 5 month period from 2nd to 3rd dose. No signs or symptoms reported, no adverse effects felt from the vaccination.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Akinesia, Atrial fibrillation, Blood lactic acid
Clinical narrative: Date of Admission  01/11/2022   Date of Discharge  01/18/2022   Reason for Hospitalization   Pt states legs are swollen.   NH reports decrease in mental status.  COVID+. was crawling on floor at NH  Hospital Course   The patient is a 79-year-old female with a medical history of vascular dementia, A. fib, hypertension, hyperlipidemia, and chronic kidney disease stage 3B who was admitted to MICU on 1/12 due to acute hypoxic respiratory failure 2/2 COVID.  She was intubated in the ED on 1/12.  Extubated on 1/15.  Since extubation she was profoundly delirious.  Transferred from MICU service to general floor on 1/16 with a sitter.  However prior to transfer, patient developed Afib RVR with hypotension.  Given 500cc fluid and started on amiodarone bolus and gtt.  Showed evidence of acute renal failure and shock liver, and continued to be profoundly encephalopathic with labored breathing.  Lactic acidosis of 17.  In consultation with palliative care, discussed goals of care and agreed to transition to comfort care measures.  Patient died at 0546 on 1/18/22.  Discharge Diagnoses      1. Acute hypoxemic respiratory failure due to COVID-19     2. Acute encephalopathy     3. Acute renal failure     4. Shock liver     5. Atrial fibrillation with rapid ventricular response     Orders:   Culture Blood  Other Diagnoses   Ongoing  A-fib  Historical  No qualifying data  Consultants  Supportive/Palliative Care   Discharge Disposition  Deceased  Physical Exam at Discharge  Vitals & Measurements  T: 36.4 °C  HR: 102  RR: 18  BP: 101/62  SpO2: 84%  WT: 63 kg  WT: 66.9 kg (Dosing)  WT: 66.9 kg (Dosing)  BMI: 23.1  BMI: 23.1      Physical exam performed by Dr (Privacy).   Called to bedside to assess patient.  No Response to verbal, tactile, or painful stimuli.  No spontaneous breath sounds, pulses, or movements.  Pupils were fixed.  Time Spent  More than 35 minutes spent in the discharge of this patient.     Addendum by (Privacy) MD, on January 19, 2022 15:25:38 (Verified)    Attestation by (Privacy) MD, on January 19, 2022 15:25 I personally saw and evaluated the patient on the result date found in the header of this document.  I independently performed the critical/key portions of the Evaluation and Management service and discussed the management with the author of this document.  I agree with everything documented above.    Called to bedside to assess patient.  No Response to verbal, tactile, or painful stimuli.  No spontaneous breath sounds, pulses, or movements.  Pupils were fixed.   Date: 1/18/2022  Time: 05:46 am  Next of kin, including husband and children are not at bedside.  Called to son to inform  They have refused autopsy. Did not notify on-call pathology resident.   Addendum by (Privacy) NSS, on January 20, 2022 11:17:30 (Verified) Result type corrected from Death Summary to Progress Note per request of (Privacy)/Note corrections inbox.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Breath sounds absent, COVID-19, Condition aggravated, Death, Delirium
Clinical narrative: Date of Admission  01/11/2022   Date of Discharge  01/18/2022   Reason for Hospitalization   Pt states legs are swollen.   NH reports decrease in mental status.  COVID+. was crawling on floor at NH  Hospital Course   The patient is a 79-year-old female with a medical history of vascular dementia, A. fib, hypertension, hyperlipidemia, and chronic kidney disease stage 3B who was admitted to MICU on 1/12 due to acute hypoxic respiratory failure 2/2 COVID.  She was intubated in the ED on 1/12.  Extubated on 1/15.  Since extubation she was profoundly delirious.  Transferred from MICU service to general floor on 1/16 with a sitter.  However prior to transfer, patient developed Afib RVR with hypotension.  Given 500cc fluid and started on amiodarone bolus and gtt.  Showed evidence of acute renal failure and shock liver, and continued to be profoundly encephalopathic with labored breathing.  Lactic acidosis of 17.  In consultation with palliative care, discussed goals of care and agreed to transition to comfort care measures.  Patient died at 0546 on 1/18/22.  Discharge Diagnoses      1. Acute hypoxemic respiratory failure due to COVID-19     2. Acute encephalopathy     3. Acute renal failure     4. Shock liver     5. Atrial fibrillation with rapid ventricular response     Orders:   Culture Blood  Other Diagnoses   Ongoing  A-fib  Historical  No qualifying data  Consultants  Supportive/Palliative Care   Discharge Disposition  Deceased  Physical Exam at Discharge  Vitals & Measurements  T: 36.4 °C  HR: 102  RR: 18  BP: 101/62  SpO2: 84%  WT: 63 kg  WT: 66.9 kg (Dosing)  WT: 66.9 kg (Dosing)  BMI: 23.1  BMI: 23.1      Physical exam performed by Dr (Privacy).   Called to bedside to assess patient.  No Response to verbal, tactile, or painful stimuli.  No spontaneous breath sounds, pulses, or movements.  Pupils were fixed.  Time Spent  More than 35 minutes spent in the discharge of this patient.     Addendum by (Privacy) MD, on January 19, 2022 15:25:38 (Verified)    Attestation by (Privacy) MD, on January 19, 2022 15:25 I personally saw and evaluated the patient on the result date found in the header of this document.  I independently performed the critical/key portions of the Evaluation and Management service and discussed the management with the author of this document.  I agree with everything documented above.    Called to bedside to assess patient.  No Response to verbal, tactile, or painful stimuli.  No spontaneous breath sounds, pulses, or movements.  Pupils were fixed.   Date: 1/18/2022  Time: 05:46 am  Next of kin, including husband and children are not at bedside.  Called to son to inform  They have refused autopsy. Did not notify on-call pathology resident.   Addendum by (Privacy) NSS, on January 20, 2022 11:17:30 (Verified) Result type corrected from Death Summary to Progress Note per request of (Privacy)/Note corrections inbox.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Encephalopathy, Endotracheal intubation, Hypotension, Intensive care
Clinical narrative: Date of Admission  01/11/2022   Date of Discharge  01/18/2022   Reason for Hospitalization   Pt states legs are swollen.   NH reports decrease in mental status.  COVID+. was crawling on floor at NH  Hospital Course   The patient is a 79-year-old female with a medical history of vascular dementia, A. fib, hypertension, hyperlipidemia, and chronic kidney disease stage 3B who was admitted to MICU on 1/12 due to acute hypoxic respiratory failure 2/2 COVID.  She was intubated in the ED on 1/12.  Extubated on 1/15.  Since extubation she was profoundly delirious.  Transferred from MICU service to general floor on 1/16 with a sitter.  However prior to transfer, patient developed Afib RVR with hypotension.  Given 500cc fluid and started on amiodarone bolus and gtt.  Showed evidence of acute renal failure and shock liver, and continued to be profoundly encephalopathic with labored breathing.  Lactic acidosis of 17.  In consultation with palliative care, discussed goals of care and agreed to transition to comfort care measures.  Patient died at 0546 on 1/18/22.  Discharge Diagnoses      1. Acute hypoxemic respiratory failure due to COVID-19     2. Acute encephalopathy     3. Acute renal failure     4. Shock liver     5. Atrial fibrillation with rapid ventricular response     Orders:   Culture Blood  Other Diagnoses   Ongoing  A-fib  Historical  No qualifying data  Consultants  Supportive/Palliative Care   Discharge Disposition  Deceased  Physical Exam at Discharge  Vitals & Measurements  T: 36.4 °C  HR: 102  RR: 18  BP: 101/62  SpO2: 84%  WT: 63 kg  WT: 66.9 kg (Dosing)  WT: 66.9 kg (Dosing)  BMI: 23.1  BMI: 23.1      Physical exam performed by Dr (Privacy).   Called to bedside to assess patient.  No Response to verbal, tactile, or painful stimuli.  No spontaneous breath sounds, pulses, or movements.  Pupils were fixed.  Time Spent  More than 35 minutes spent in the discharge of this patient.     Addendum by (Privacy) MD, on January 19, 2022 15:25:38 (Verified)    Attestation by (Privacy) MD, on January 19, 2022 15:25 I personally saw and evaluated the patient on the result date found in the header of this document.  I independently performed the critical/key portions of the Evaluation and Management service and discussed the management with the author of this document.  I agree with everything documented above.    Called to bedside to assess patient.  No Response to verbal, tactile, or painful stimuli.  No spontaneous breath sounds, pulses, or movements.  Pupils were fixed.   Date: 1/18/2022  Time: 05:46 am  Next of kin, including husband and children are not at bedside.  Called to son to inform  They have refused autopsy. Did not notify on-call pathology resident.   Addendum by (Privacy) NSS, on January 20, 2022 11:17:30 (Verified) Result type corrected from Death Summary to Progress Note per request of (Privacy)/Note corrections inbox.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Ischaemic hepatitis, Lactic acidosis, Mental status changes, Peripheral swelling, Pulse absent
Clinical narrative: Date of Admission  01/11/2022   Date of Discharge  01/18/2022   Reason for Hospitalization   Pt states legs are swollen.   NH reports decrease in mental status.  COVID+. was crawling on floor at NH  Hospital Course   The patient is a 79-year-old female with a medical history of vascular dementia, A. fib, hypertension, hyperlipidemia, and chronic kidney disease stage 3B who was admitted to MICU on 1/12 due to acute hypoxic respiratory failure 2/2 COVID.  She was intubated in the ED on 1/12.  Extubated on 1/15.  Since extubation she was profoundly delirious.  Transferred from MICU service to general floor on 1/16 with a sitter.  However prior to transfer, patient developed Afib RVR with hypotension.  Given 500cc fluid and started on amiodarone bolus and gtt.  Showed evidence of acute renal failure and shock liver, and continued to be profoundly encephalopathic with labored breathing.  Lactic acidosis of 17.  In consultation with palliative care, discussed goals of care and agreed to transition to comfort care measures.  Patient died at 0546 on 1/18/22.  Discharge Diagnoses      1. Acute hypoxemic respiratory failure due to COVID-19     2. Acute encephalopathy     3. Acute renal failure     4. Shock liver     5. Atrial fibrillation with rapid ventricular response     Orders:   Culture Blood  Other Diagnoses   Ongoing  A-fib  Historical  No qualifying data  Consultants  Supportive/Palliative Care   Discharge Disposition  Deceased  Physical Exam at Discharge  Vitals & Measurements  T: 36.4 °C  HR: 102  RR: 18  BP: 101/62  SpO2: 84%  WT: 63 kg  WT: 66.9 kg (Dosing)  WT: 66.9 kg (Dosing)  BMI: 23.1  BMI: 23.1      Physical exam performed by Dr (Privacy).   Called to bedside to assess patient.  No Response to verbal, tactile, or painful stimuli.  No spontaneous breath sounds, pulses, or movements.  Pupils were fixed.  Time Spent  More than 35 minutes spent in the discharge of this patient.     Addendum by (Privacy) MD, on January 19, 2022 15:25:38 (Verified)    Attestation by (Privacy) MD, on January 19, 2022 15:25 I personally saw and evaluated the patient on the result date found in the header of this document.  I independently performed the critical/key portions of the Evaluation and Management service and discussed the management with the author of this document.  I agree with everything documented above.    Called to bedside to assess patient.  No Response to verbal, tactile, or painful stimuli.  No spontaneous breath sounds, pulses, or movements.  Pupils were fixed.   Date: 1/18/2022  Time: 05:46 am  Next of kin, including husband and children are not at bedside.  Called to son to inform  They have refused autopsy. Did not notify on-call pathology resident.   Addendum by (Privacy) NSS, on January 20, 2022 11:17:30 (Verified) Result type corrected from Death Summary to Progress Note per request of (Privacy)/Note corrections inbox.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pupil fixed, SARS-CoV-2 test positive, Unresponsive to stimuli
Clinical narrative: Date of Admission  01/11/2022   Date of Discharge  01/18/2022   Reason for Hospitalization   Pt states legs are swollen.   NH reports decrease in mental status.  COVID+. was crawling on floor at NH  Hospital Course   The patient is a 79-year-old female with a medical history of vascular dementia, A. fib, hypertension, hyperlipidemia, and chronic kidney disease stage 3B who was admitted to MICU on 1/12 due to acute hypoxic respiratory failure 2/2 COVID.  She was intubated in the ED on 1/12.  Extubated on 1/15.  Since extubation she was profoundly delirious.  Transferred from MICU service to general floor on 1/16 with a sitter.  However prior to transfer, patient developed Afib RVR with hypotension.  Given 500cc fluid and started on amiodarone bolus and gtt.  Showed evidence of acute renal failure and shock liver, and continued to be profoundly encephalopathic with labored breathing.  Lactic acidosis of 17.  In consultation with palliative care, discussed goals of care and agreed to transition to comfort care measures.  Patient died at 0546 on 1/18/22.  Discharge Diagnoses      1. Acute hypoxemic respiratory failure due to COVID-19     2. Acute encephalopathy     3. Acute renal failure     4. Shock liver     5. Atrial fibrillation with rapid ventricular response     Orders:   Culture Blood  Other Diagnoses   Ongoing  A-fib  Historical  No qualifying data  Consultants  Supportive/Palliative Care   Discharge Disposition  Deceased  Physical Exam at Discharge  Vitals & Measurements  T: 36.4 °C  HR: 102  RR: 18  BP: 101/62  SpO2: 84%  WT: 63 kg  WT: 66.9 kg (Dosing)  WT: 66.9 kg (Dosing)  BMI: 23.1  BMI: 23.1      Physical exam performed by Dr (Privacy).   Called to bedside to assess patient.  No Response to verbal, tactile, or painful stimuli.  No spontaneous breath sounds, pulses, or movements.  Pupils were fixed.  Time Spent  More than 35 minutes spent in the discharge of this patient.     Addendum by (Privacy) MD, on January 19, 2022 15:25:38 (Verified)    Attestation by (Privacy) MD, on January 19, 2022 15:25 I personally saw and evaluated the patient on the result date found in the header of this document.  I independently performed the critical/key portions of the Evaluation and Management service and discussed the management with the author of this document.  I agree with everything documented above.    Called to bedside to assess patient.  No Response to verbal, tactile, or painful stimuli.  No spontaneous breath sounds, pulses, or movements.  Pupils were fixed.   Date: 1/18/2022  Time: 05:46 am  Next of kin, including husband and children are not at bedside.  Called to son to inform  They have refused autopsy. Did not notify on-call pathology resident.   Addendum by (Privacy) NSS, on January 20, 2022 11:17:30 (Verified) Result type corrected from Death Summary to Progress Note per request of (Privacy)/Note corrections inbox.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: I was informed that a child age 13 was given a pediatric dose. The child was screened prior to reaching me. The screener informed me that the child met criteria for pediatric dose.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: generalized malaise and not feeling well.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Patient's daughter called pharmacy on 02/24/2022 to notify her mom received Moderna Booster 02/17/2022 and started having rash on torso on 02/19/2022.  The rash was reported and itchiness with no pain. The rash gradually worsen over time and was spreading to her face and scalp on 02/24/2022. Daughter stated he mom tried 4 tablets of diphenhydramine and it did not help with the itchiness nor did it help with the rash spreading. Atarax 25mg was written for the patient. Patient told that if symptoms worsen or included difficulty breathing to go to the emergency room
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitalization with Covid-19; fully vaccinated with booster.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt admitted with covid infection
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure
Clinical narrative: Acute on chronic respiratory failure requiring hospitalization
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Acute respiratory failure, Angiogram abnormal, Arteriosclerosis, Atelectasis
Clinical narrative: Patient expired. 63 year old male with history of Ulcerative colitis (on Xeljanz and Sulfasalazine) with prior history of DVT (on Eliquis) with recent admission 1/20-2/4 due to UC flare complicated by colonic perforation who underwent total abdominal colectomy with end-ileostomy 1/28. He was discharged home but was re-admitted 2/7 due small bowel obstruction. He was also found to have portal vein thrombosis and was incidentally found to be COVID 19 positive. He was treated non-operatively with NGT and foley catheter placed in stoma. He was treated with Unasyn for possible aspiration given bibasilar infiltrates noted on CT. For COVID 19, he was started on Decadron course. Given persistent ileus/SBO, the patient was started on TPN 2/13 after RIJ CVC was placed. On 2/14 AM, the patient developed severe abdominal pain associated with decreased ostomy output, hypotension and tachycardia. He was brought to CT and was found to have increased intra-abdominal free air and increased small bowel wall thickening. On arrival to ICU he only required low dose vasopressors but quickly decompensated and was taken to OR which noted possible perforation located at the GE junction, feculent peritonitis. He returned to the ICU requiring high dose quad pressor support. Family updated and transitioned patient to comfort care. He was pronounced dead at 2050.    Medical Examiner Case Assessment Select Applicable Patient Criteria: Does not meet any of the listed criteria
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Bladder catheterisation, Bronchial secretion retention, Bronchiectasis, COVID-19, Central venous catheterisation
Clinical narrative: Patient expired. 63 year old male with history of Ulcerative colitis (on Xeljanz and Sulfasalazine) with prior history of DVT (on Eliquis) with recent admission 1/20-2/4 due to UC flare complicated by colonic perforation who underwent total abdominal colectomy with end-ileostomy 1/28. He was discharged home but was re-admitted 2/7 due small bowel obstruction. He was also found to have portal vein thrombosis and was incidentally found to be COVID 19 positive. He was treated non-operatively with NGT and foley catheter placed in stoma. He was treated with Unasyn for possible aspiration given bibasilar infiltrates noted on CT. For COVID 19, he was started on Decadron course. Given persistent ileus/SBO, the patient was started on TPN 2/13 after RIJ CVC was placed. On 2/14 AM, the patient developed severe abdominal pain associated with decreased ostomy output, hypotension and tachycardia. He was brought to CT and was found to have increased intra-abdominal free air and increased small bowel wall thickening. On arrival to ICU he only required low dose vasopressors but quickly decompensated and was taken to OR which noted possible perforation located at the GE junction, feculent peritonitis. He returned to the ICU requiring high dose quad pressor support. Family updated and transitioned patient to comfort care. He was pronounced dead at 2050.    Medical Examiner Case Assessment Select Applicable Patient Criteria: Does not meet any of the listed criteria